The activation of RIPK1 kinase activity is involved in mediating pathological cell death and inflammation in a wide arrange of major human diseases from peripheral rheumatoid arthritis and Crohn’s disease to neurodegenerative disorders such as amyotrophic lateral sclerosis and Alzheimer’s disease (10–13). This evidence concerns the gene RIPK1 and early-onset autosomal dominant Alzheimer disease.